News

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial ...
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...
Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...
Understand how semaglutide shows strong benefits in MASH treatment, improving liver health and reducing weight.
Chances are, you haven’t heard of metabolic dysfunction–associated steatohepatitis (MASH)—but you’ve almost definitely heard ...
semaglutide resolved steatohepatitis in 63% of patients and reduced liver fibrosis, while also promoting weight loss and improving metabolic health in people with advanced fatty liver disease.